US2020360567A1PendingUtilityA1
Tubular tissue construct and a method of printing
Est. expiryMay 5, 2035(~8.8 yrs left)· nominal 20-yr term from priority
A61L 27/56C12N 5/0686A61L 27/3834A61L 27/3633A61L 27/3675A61L 27/3891A61L 27/3808B29C 64/106A61L 27/50A61L 27/54A61L 2300/64A61L 2430/26A61L 2400/08A61L 2300/62B33Y 10/00A61F 2240/002A61L 27/3878A61L 2430/32A61F 2/04A61L 27/18B33Y 80/00A61L 27/3804
61
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A 3D printed tubular construct, such as a nephron, with or without embedded vasculature as well as methods of printing tubular tissue constructs are described.
Claims
exact text as granted — not AI-modified1 .- 58 . (canceled)
59 . A 3D printed nephron comprising:
one or more functional channels comprising a patterned cell layer thereon along the length of the functional channel, wherein the patterned cell layer comprises
renal proximal tubule cells over a first predetermined length of the one or more functional channels,
loop of Henle cells over a second predetermined length of the one or more functional channels, and
renal distal tubule cells over a third predetermined length of the one or more functional channels; and
an extracellular matrix composition at least partially surrounding the one or more functional channels.
60 . The 3D printed nephron of claim 59 , further comprising one or more tissue patterns, each tissue pattern comprising a plurality of viable cells of one or more predetermined cell types, wherein the extracellular matrix composition at least partially surrounds the one or more tissue patterns.
61 . The 3D printed nephron of claim 59 , further comprising an interpenetrating network of tubes in the extracellular matrix composition.
62 . The 3D printed nephron of claim 61 , wherein the interpenetrating network of tubes comprises a vascular pattern interpenetrating the functional channels.
63 .- 93 . (canceled)
94 . The 3D printed nephron of claim 59 , wherein the extracellular matrix composition comprises one or more of gelatin, fibrin, gelatin methacrylate, collagen I, collagen III, collagen IV, fibrinogen, matrigel, laminin, carbopol, N-isopropylacrylamide, polyethylene glycol, gelatin methacrylate, polyhydroxyethylmethacrylate, silk, hyaluronic acid, proteoglycans, and/or combinations thereof.Join the waitlist — get patent alerts
Track US2020360567A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.